"M Health Fairview Masonic Children’s Hospital provides a broad range of more than 55 pediatric programs and specialties from surgery, imaging and neonatal and pediatric intensive care to cardiac and oncology services and blood and marrow and organ transplantation. Our clinical staff apply innovative approaches to creating medical breakthroughs based their work with patients and on findings through research at the University of Minnesota. This has led to several firsts, including the first successful pediatric blood marrow transplant, infant heart transplant in Minnesota and cochlear ear implant surgery for a child."

During the past decade, University of Minnesota Masonic Children's Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 22 clinical trials were completed, i.e. on average, 62.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 15 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Minnesota Masonic Children's Hospital" #1 sponsor was "Children's Oncology Group" with 9 trials, followed by "Masonic Cancer Center, University of Minnesota" with 6 trials sponsored, "University of Minnesota" with 6 trials sponsored, "Pfizer" with 3 trials sponsored and "Therapeutic Advances in Childhood Leukemia Consortium" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota Masonic Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator and "Akron Children's Hospital" with 1 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "University of Minnesota Masonic Children's Hospital" are "Leukemia" (5 trials), "Lymphoma" (5 trials), "Sarcoma" (5 trials), "Breast Cancer" (3 trials) and "Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "University of Minnesota Masonic Children's Hospital" in a lesser frequency.

Most popular intervention types in "University of Minnesota Masonic Children's Hospital" are "Drug" (42 trials), "Other" (10 trials), "Biological" (9 trials), "Device" (8 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Minnesota Masonic Children's Hospital" are 58 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Minnesota Masonic Children's Hospital". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in University of Minnesota Masonic Children's Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Minnesota Masonic Children's Hospital, 8 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".